EW Q1 2024 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$50B

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.3B-8.9% YoY

Gross Profit

$1.0B78.2% margin

Operating Income

$356M26.7% margin

Net Income

$352M26.5% margin

EPS (Diluted)

$0.58

QoQ Revenue Growth

+5.0%

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$139M

Stock-Based Comp.

$45M

Balance Sheet

Total Assets

$9.7B

Total Liabilities

$2.5B

Stockholders' Equity

$7.1B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$1.5B	-8.9%
Gross Profit	$1.0B	$1.1B	-5.4%
Operating Income	$356M	$403M	-11.7%
Net Income	$352M	$341M	+3.3%

Revenue Segments

Transcatheter Heart Valves

$1.0B63%

Surgical Heart Valve Therapy

$266M17%

Critical Care

$251M16%

Transcatheter Mitral And Tricuspid Therapies

$73M5%

Geographic Segments

UNITED STATES

$941M59%

Europe

$368M23%

Rest of World

$179M11%

JAPAN

$111M7%